Deal Announcements

Cempra Pharmaceuticals Nets $10 Million Series B

Friday, February 01, 2008 6:14:00 AM PDT | VentureDeal Staff

MORRISVILLE, NC -- Cempra Pharmaceuticals, Inc. has received $10 million in a second round of venture capital investment from existing investors.

Cempra is developing medicines to help fight drug-resistant bacterial infections in the community and inside hospitals.

Past investors Aisling Capital and Intersouth Partners invested in the round.  Funding proceeds were not disclosed by the company.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1